Home

Aethlon Medical, Inc. - Common Stock (AEMD)

0.6999
-0.0301 (-4.12%)

Aethlon Medical is a clinical-stage company focused on the development of innovative therapeutic solutions aimed at addressing unmet medical needs, particularly in the areas of infectious diseases and cancer

The company is primarily known for its work on the Aethlon Hemopurifier, a device designed to selectively remove pathogens and other harmful substances from the blood. Aethlon Medical is dedicated to advancing its technologies through rigorous clinical studies, with the goal of improving patient outcomes and enhancing the effectiveness of current treatment options.

SummaryNewsPress ReleasesChartHistoricalFAQ
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
By Virtual Investor Conferences · Via GlobeNewswire · September 20, 2024
Immunotherapy Clinical Trials - A New Approach to Treating Cancer
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - September 19, 2024) - Investorideas.com, a go-to investing platform, releases the ...
Via Newsfile · September 19, 2024
Innovation Driving Cancer's Solid Tumors Market
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - September 17, 2024) - Investorideas.com, a go-to investing platform, releases the...
Via Newsfile · September 17, 2024
Life Sciences Virtual Investor Forum Agenda Announced for September 19th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
By Virtual Investor Conferences · Via GlobeNewswire · September 16, 2024
Aethlon Medical to Present at the Life Sciences Investor Forum September 19th
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
By Virtual Investor Conferences · Via GlobeNewswire · September 13, 2024
The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - August 12, 2024) - Investorideas.com, a go-to investing platform covering biotech and...
Via Newsfile · August 12, 2024
What's Next in Treatments for Cancer Patients with Solid Tumors?
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - June 20, 2024) - Investorideas.com, a go-to investing platform, releases an industry...
Via Newsfile · June 20, 2024
Exploring Top NASDAQ Stocks Under $1 Gaining Traction: KITT, AEMD, VTAK, TELL, KWE
The NASDAQ, one of the world's largest stock exchanges, witnesses billions in daily trades across diverse stocks. Among various stock categories, penny stocks trading under $1 a share are particularly noteworthy. This article delves into five such NASDAQ-listed stocks, offering insights and potential investment opportunities.
Via AB Newswire · June 11, 2024
The Hunt for Virus Treatments Continues Post Covid-19
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - June 7, 2024) - Investorideas.com, a go-to investing platform, releases the second...
Via Newsfile · June 7, 2024
RJD Green Inc. (OTC: RJDG) Stock Surges Amid Investor Interest on Record Revenues
RJD Green Inc. (OTC: RJDG) captured significant investor attention, leading to a substantial stock gain of 29.5% on June 5, 2024. The trading volume surged to nine times the average daily volume. The company announced that its business unit, Silex Holdings Inc., achieved its highest monthly revenue since its establishment in June 2006. In May, Silex Holdings, Inc., a division of RJD Green, recorded $865,730 in revenues and a net operating profit of $242,404 . For context, the average annual revenue from Silex over the past two years was $4,800,000, with May 2024 revenues accounting for 18.1% of the annual income in 2023.
Via AB Newswire · June 6, 2024
Blood Purification Medical Devices Revolutionizing the Future of Health from Cancer to COVID
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - June 3, 2024) - Investorideas.com, a go-to investing platform, releases the first...
Via Newsfile · June 3, 2024